Acute Kidney Injury, Chronic Renal Failure, Glomerulonephritis - Nursing Case Study

Pathophysiology

• Acute Kidney Injury (AKI): Rapid decline in renal function due to decreased blood flow (prerenal), direct nephron damage (intrarenal), or obstruction (postrenal), leading to accumulation of waste products and electrolyte imbalance.

• Chronic Renal Failure (CRF): Progressive nephron loss from persistent hypertension or diabetes, causing glomerular hyperfiltration and sclerosis, leading to uremia and systemic complications like cardiovascular disease.

• Glomerulonephritis: Immune-mediated glomerular inflammation, often triggered by infections or autoimmune conditions, causing glomerular basement membrane damage and proteinuria, eventually progressing to nephron damage and renal insufficiency.

Patient Profile

Demographics:

62-year-old male, retired chemical engineer

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Stage 3 Chronic Kidney Disease, Recurrent Urinary Tract Infections

• Current medications: Lisinopril, Metformin, Furosemide, Insulin, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe shortness of breath and swelling in legs

• Key symptoms: Fatigue, decreased urine output, confusion, nausea, flank pain

• Vital signs: Blood pressure 180/110 mmHg, heart rate 120 bpm, respiratory rate 28 breaths per minute, temperature 101.2°F, oxygen saturation 85% on room air

Section 1

Initial Assessment Findings:

Upon initial assessment, the patient exhibits significant signs of fluid overload and respiratory distress. Auscultation of the lungs reveals bilateral crackles, more pronounced at the bases, indicating potential pulmonary edema. There is notable pitting edema in both lower extremities, extending up to the knees, suggesting substantial fluid retention. The patient is visibly distressed, using accessory muscles to breathe, and requires immediate supplemental oxygen via a non-rebreather mask, which improves his oxygen saturation to 92%. Neurologically, the patient displays altered mental status with periods of confusion and disorientation, raising concerns for uremic encephalopathy or severe electrolyte imbalance.

Laboratory results reinforce the critical nature of his condition: blood urea nitrogen (BUN) is markedly elevated at 78 mg/dL, creatinine has risen sharply to 5.6 mg/dL, and glomerular filtration rate (GFR) has plummeted to below 15 mL/min/1.73m², confirming acute on chronic renal failure. Electrolyte analysis reveals hyperkalemia with potassium levels at 6.5 mEq/L, and metabolic acidosis with a bicarbonate level of 14 mEq/L. The urinalysis shows significant proteinuria and microscopic hematuria, consistent with ongoing glomerulonephritis activity. These findings necessitate immediate nephrology consultation and potential initiation of renal replacement therapy.

The patient's hemodynamic instability, evidenced by hypertension and tachycardia, may reflect an overactive renin-angiotensin-aldosterone system due to compromised renal perfusion and failing renal autoregulation. Immediate interventions focus on stabilizing his cardiovascular status, managing fluid overload with cautious diuretic administration, and addressing the electrolyte imbalances. This complex clinical picture requires vigilant monitoring for potential deterioration, and decisions regarding dialysis initiation must weigh the risks and benefits amidst his multiple comorbidities.

Section 2

Change in Patient Status:

Despite initial interventions, the patient's condition deteriorates, prompting an urgent reassessment. His respiratory distress intensifies, with oxygen saturation dropping to 88% despite high-flow oxygen therapy, indicating worsening pulmonary edema. Crackles now extend throughout all lung fields, and the patient is increasingly tachypneic, with a respiratory rate of 34 breaths per minute. The development of frothy sputum and a persistent dry cough suggest acute cardiogenic pulmonary edema, possibly exacerbated by aggressive fluid shifts and impaired renal excretion.

Neurologically, the patient exhibits further decline with increased confusion and agitation, compounded by the potential of escalating uremic toxins or worsening metabolic acidosis. His blood pressure has surged to 190/110 mmHg, and heart rate remains elevated at 115 beats per minute, raising concerns for hypertensive emergency and its potential impact on cerebral autoregulation. Electrolyte analysis reveals a critical potassium level increased further to 7.2 mEq/L, posing an imminent risk for life-threatening cardiac arrhythmias. Additionally, his bicarbonate level has dropped to 12 mEq/L, indicating worsening metabolic acidosis.

In response to these alarming changes, the healthcare team prioritizes airway management and circulatory support. A decision is made to initiate emergent renal replacement therapy to rapidly manage electrolyte imbalances, fluid overload, and toxin clearance. Continuous renal replacement therapy (CRRT) is favored due to the patient's hemodynamic instability, allowing for more gradual fluid and solute removal. Concurrently, intravenous antihypertensive agents are administered to rapidly bring blood pressure under control. As the team works to stabilize the patient, there is a heightened awareness of the potential for further complications, such as myocardial ischemia or cerebral edema, necessitating continuous monitoring and potential escalation of care.

Section 3

Response to Interventions:

Following the initiation of continuous renal replacement therapy (CRRT), the patient's condition shows initial signs of stabilization. Over the next few hours, careful monitoring reveals a gradual improvement in electrolyte balance, with potassium levels declining to 5.8 mEq/L, providing a slight reprieve from the immediate risk of cardiac arrhythmias. However, the patient's metabolic acidosis persists, with bicarbonate levels only marginally increasing to 14 mEq/L, signaling the need for ongoing correction and close observation. The aggressive antihypertensive therapy begins to take effect, with blood pressure reducing to 160/95 mmHg, though careful titration continues to avoid rapid changes that could precipitate further cerebral or myocardial complications.

Despite these initial positive responses, the patient's respiratory status remains precarious. The high-flow oxygen therapy is maintained, yet oxygen saturation hovers around 90%, and the patient remains tachypneic with a respiratory rate of 32 breaths per minute. The presence of diffuse crackles in all lung fields and persistent frothy sputum underscores the challenge of managing fluid overload in the context of impaired renal function and cardiogenic pulmonary edema. The healthcare team considers the possibility of implementing non-invasive positive pressure ventilation (NIPPV) to enhance oxygenation and reduce the work of breathing, weighing the potential benefits against the risk of further hemodynamic compromise.

As the team continues to monitor the patient's response, there is a palpable concern about the potential for new complications. The persistence of neurological symptoms, including confusion and agitation, raises the suspicion of advancing uremic encephalopathy or the emergence of hypertensive crisis-related cerebral edema. With these considerations in mind, the interdisciplinary team remains vigilant, ready to escalate care with advanced neuroimaging or further cardiovascular support if necessary, underscoring the complexity of managing this critically ill patient.

Section 4

Change in Patient Status:

Despite the initial stabilization following CRRT and antihypertensive therapy, the patient's condition takes a concerning turn. The respiratory status, already tenuous, worsens over the next few hours. Oxygen saturation drops to 85% despite the continuation of high-flow oxygen, and the patient's respiratory rate spikes to 38 breaths per minute. Auscultation now reveals louder bilateral crackles with diminished breath sounds at the lung bases, suggesting an escalation of pulmonary edema. In response, the team initiates non-invasive positive pressure ventilation (NIPPV), aiming to improve alveolar recruitment and gas exchange. However, the patient exhibits signs of increased respiratory distress, struggling against the ventilation, and the medical team needs to consider potential intubation if the status does not improve.

Simultaneously, the patient's neurological state deteriorates. Previously noted confusion and agitation have progressed to decreased responsiveness, with a Glasgow Coma Scale (GCS) score dropping to 9, indicating a need for urgent evaluation. Suspecting worsening uremic encephalopathy or cerebral edema due to hypertensive crisis, the team orders an urgent CT scan of the head. Laboratory results further complicate the picture: blood urea nitrogen (BUN) has increased to 98 mg/dL and creatinine remains elevated at 6.9 mg/dL, confirming ongoing renal impairment, while ammonia levels are significantly raised, reinforcing the suspicion of encephalopathy.

In light of these developments, the interdisciplinary team must rapidly reassess the plan of care. The possibility of initiating more aggressive renal support, such as hemodialysis, is considered to manage the rising toxin levels. Additionally, continuous EEG monitoring may be warranted to evaluate the potential for subclinical seizures. As the patient's condition becomes increasingly unstable, the team prepares to escalate to more intensive interventions, aware that each decision carries significant risks and requires precise clinical judgment to navigate the complex interplay of multi-organ dysfunction.

Section 5

New Diagnostic Results:

As the medical team proceeds with the urgent CT scan of the patient's head, they discover evidence of mild cerebral edema, consistent with the clinical suspicion of uremic encephalopathy exacerbated by hypertensive crisis. This finding corroborates the neurological decline observed in the patient and underscores the pressing need for aggressive management of the underlying renal and systemic issues. Concurrently, a continuous EEG is initiated, revealing intermittent bursts of high-amplitude slow waves without definitive seizure activity, but raising concerns about the potential for evolving non-convulsive status epilepticus. These neurological insights prompt a critical re-evaluation of the patient's treatment plan.

In addition to the neurological diagnostic results, a comprehensive assessment of the patient's metabolic and respiratory status is completed. Arterial blood gas analysis shows a severe metabolic acidosis with a pH of 7.15, bicarbonate level of 12 mEq/L, and a compensatory respiratory alkalosis, as indicated by a pCO2 of 28 mmHg. These findings highlight the significant acid-base disturbance, likely a consequence of the acute renal failure and exacerbation of chronic renal insufficiency. The patient's lactate level is also elevated at 4.5 mmol/L, suggesting possible tissue hypoperfusion or underlying sepsis, which complicates the clinical picture further and necessitates immediate intervention to prevent further deterioration.

The laboratory results, combined with the imaging and electroencephalographic findings, compel the interdisciplinary team to expedite the decision to initiate urgent hemodialysis. The goal is to rapidly reduce the toxic metabolite burden, correct the severe metabolic acidosis, and improve the patient's neurological status. As preparations for hemodialysis are made, the team discusses the need for careful monitoring of hemodynamic stability, given the patient's precarious condition, and the potential requirement for vasopressor support to maintain adequate perfusion during this critical intervention.